Neylan John F. 4
4 · Angion Biomedica Corp. · Filed Apr 20, 2021
Insider Transaction Report
Form 4
Neylan John F.
See Remarks
Transactions
- Sale
Common Stock
2021-04-19$13.55/sh−381$5,163→ 38,092 total
Footnotes (1)
- [F1]The shares reported in this Form 4 were sold pursuant to a 10b5-1 trading plan adopted by the reporting person solely to satisfy tax or other government withholding obligations in connection with the vesting of shares of Restricted Stock of the Issuer.